Published in Blood Weekly, February 10th, 2011
"We classified the patients according to the duration of hemodialysis therapy (less than 10 years, 10-20 years, 20-30 years, or over 30 years) and compared the laboratory and anthropometric data. No significant differences in age or the total protein, albumin, total cholesterol, triglyceride or CRP levels were observed. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.